| Financial Year |
March 31 2022 |
| Monetary Funds |
310,238,834.66 |
| Held-for-trading Financial Assets |
561,983,584.95 |
| Notes Receivable |
33,983,538.87 |
| Accounts Receivable |
373,315,586.51 |
| Advances to Suppliers |
10,798,732.46 |
| Other Receivables |
9,939,153.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
46,194,610.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,652,171.00 |
| Total Current Assets |
1,399,750,837.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,450,985.27 |
| Investment Properties |
-- |
| Fixed Assetes |
145,889,676.60 |
| Under-construction Projects |
6,766,310.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
160,483,709.79 |
| R&D expenses |
-- |
| Goodwill |
72,366,141.30 |
| Long-Term Deferred and Prepaid Expenses |
13,195,728.20 |
| Deferred Income Tax Assets |
6,501,979.09 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
518,929,570.40 |
| Total Assets |
1,918,680,407.82 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
44,032,555.21 |
| Accounts Payable |
322,926,469.48 |
| Accounts Received In Advance |
412,683.51 |
| Employee Compensation Payable |
38,448,789.86 |
| Taxes Payable |
26,928,002.07 |
| Interest Payable |
-- |
| Dividend Payable |
3,773,690.57 |
| Other payables |
62,195,075.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
40,042,987.50 |
| Other Current Liabilities |
3,521,279.69 |
| Sub-Total of Current Liabilities |
538,542,325.21 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
952,920.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,776,241.02 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
62,901,924.10 |
| Total Liabilities |
601,444,249.31 |
| Paid-In Capital(Or Share Stock) |
133,340,000.00 |
| Capital Surplus |
444,627,603.52 |
| Surplus Reserve |
33,421,099.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
605,180,896.63 |
| Minority Stockholder's Interest |
83,026,567.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,234,209,591.37 |
| Owner's Equity（Stockholder's Equity） |
1,317,236,158.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,918,680,407.82 |
